期刊文献+

骨桥蛋白在体外诱导大鼠骨髓基质干细胞向成骨细胞分化中的作用 被引量:3

Effects of osteopontin in mice bone marrow-derived mesenchymal stem cells differentiating into osteoblasts in vitro
下载PDF
导出
摘要 目的:观察骨桥蛋白是否能诱导体外培养的大鼠骨髓基质干细胞(BMSCs)向成骨细胞分化,探讨其在骨折愈合过程中的作用机制,为其以后在骨折愈合方面的研究提供确切的理论依据。方法:以冲洗法获取Wistar大鼠骨髓,用贴壁法分离提纯BMSCs,传至第3代后分组,体外培养的BMSCs分为实验组和对照组,实验组添加含0.2nmol/L骨桥蛋白的DMEM条件培养基;对照组为不含骨桥蛋白的DMEM培养基,于不同时间点收集细胞。通过光镜观察培养的细胞形态,以细胞计数法测定生长曲线,应用流式细胞仪分析细胞周期,并行碱性磷酸酶(ALP)染色和活性测定及骨钙素(OCN)含量测定。结果:实验组细胞具有成骨细胞的形态学特征;实验组细胞生长曲线右移,细胞G0/G1期比例平均增加13.17%(P<0.01),S期比例减少74.93%(P<0.01);实验组ALP染色呈阳性,且ALP活性、OCN含量均较对照组明显提高。结论:骨桥蛋白对BMSCs有促进成骨分化的作用。 Objective:To explore whether osteopontin (OPN) can induce in vitro bone marrow-derived mesenchymal stem cells (BMSCs) to differentiate into osteoblasts,and explore its mechanism in the union of fracture to provide exact theoretical basis for its further study in the union of fracture. Methods:The bone marrow was separated from the bone of limbs of rats and isolated and then purified using adherence filtration. The passage cells of the third generation were divided into groups. BMSCs were cultured and divided into experimental group and control group. In the experimental group,the culture medi-um contained 0.2 nmol/L OPN. Cell morphology was observed by the light microscope,cell growth curve was tested by cell number counting method,cell cycle was examined with flow cytometry. Alkaline phosphatase (ALP) staining and activity,osteocalcin (OCN) content were measured. Results:The experimental group cells had osteoblasts-like morphology; cell growth curve of experimental group moved rightward,fluorescence at G0/G1 phase increased 13.17% (P0.01) and that at S phase decreased 74.93% (P0.01); ALP staining of experimental group cells was positive,ALP activity and OCN content of experimental group cells increased obviously compared with that of control group. Conclusion:OPN can improve the osteogenic differentiation of BMSCs.
出处 《中国医药导报》 CAS 2009年第36期14-16,共3页 China Medical Herald
关键词 骨桥蛋白 骨髓基质干细胞 成骨细胞 Osteopontin Bone marrow-derived mesenchymal stem cells Osteoblasts
  • 相关文献

参考文献12

  • 1Shin M, Yoshimoto H, Vacanti JP. In vivo tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold [J]. Tissue Eng,2004,10( 1-2):33-41.
  • 2Harris CT, Cooper LF. Comparison of bone graft matrices for humanmesenchymal stem cell-directed osteogenesis [J]. Biomed Mater Res,2004,68 (4):747-755.
  • 3唐耀亮,赵强,葛均波,储以微,王春生,胡美玉,杨英珍,刘康达.体外诱导大鼠骨髓基质细胞向心肌细胞的分化[J].复旦学报(医学版),2002,29(5):329-332. 被引量:9
  • 4王敏,翁雨来,胡晓洁,张艳,柴岗,祝联,刘伟,崔磊,冯希平,曹谊林.组织工程技术修复犬牙槽骨缺损的实验研究[J].中华医学杂志,2003,83(15):1339-1344. 被引量:28
  • 5Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy [J]. Cell Mol Med,2004,8(3):301-316.
  • 6Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell- based tissue engineering [J]. Arthtitis Res Ther,2003,5(1):32-45.
  • 7Kassem M, Kristiansen M, Abdallah BM: Mesenchymal stem cells: cell biology and potential use in therapy [J]. Basic Clin Pharmacol Toxicol, 2004,95(5):209-214.
  • 8Gericke A, Qin C, Spevak L, et al. Importance of phosphorylation for osteopontinre gulation of biomineralization [J]. Calcif Tissue Int,2005,77(1): 45 -54.
  • 9Dormady SP, Dougherty R. Immortalized multipotential mesenchymal cells and the hematopoietic mice roenvironment [J]. J Hemitter Stem Cells, 2001,10(1):125-140.
  • 10王蓓,汪维伟.间充质干细胞的研究进展[J].国外医学(外科学分册),2005,32(6):459-462. 被引量:18

二级参考文献44

  • 1汤苏阳,艾玉峰,董兆麟,杨青芳,蔡宝仁.新型生物可降解性材料聚β-羟基丁酸生物相容性和安全性研究[J].中国组织工程研究与临床康复,2001,10(14):50-51. 被引量:3
  • 2胡晓洁,王敏,刘德莉,刘伟,曹谊林.应用GFP基因转染技术示踪组织工程技术构建角膜基质[J].眼科研究,2003,21(3):238-241. 被引量:4
  • 3Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol,1966, 16: 381-390.
  • 4Gang EJ, Hong SH, Jeong JA, et al. In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells.Biochem Biophys Res Commun, 2004, 321(1): 102-108.
  • 5Yen BL, Huang HI, Chien CC, et al. Isolation of multipotent cells from human term placenta. Stem Cells, 2005, 23(1): 3-9.
  • 6Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 2003, 21(1):105-110.
  • 7In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 2004, 22(7): 1338-1345.
  • 8Kuznetsov SA, Mankani MH, Gronthos S, et al. Evidence for circulating osteogenic progenitos in humans and other mammals.Bone, 1998, 23(5): 211.
  • 9Stute N, Holtz K, Bubenheim M, et al. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol, 2004, 32(12): 1212-1225.
  • 10Justesen J, stenderup K, Eriksen EF, et al. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int,2002, 71(1): 36-44.

共引文献54

同被引文献9

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部